Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep418 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

New-onset diabetes after transplantation (NODAT). A case report

Contreras Pascual Cristina , Gonzalez Lazaro Paloma , Moreno Tirado Antonio , Montero Benitez Maria Zhao , Alvarez Lopez Susana

New-onset diabetes after transplantation (NODAT) is a serious complication after a solid organ transplantation. It has been reported to occur in 4% to 25% of renal transplant recipients, 2.5% to 25% of liver transplant recipients, 40% to 60% of hepatitis C virus (HCV) infection and 2% to 53% of all solid organ transplantations. The diagnosis is performed using unmodified criteria for diagnosing diabetes in the general population and risk factors are the commonly recognized fac...

ea0081p402 | Pituitary and Neuroendocrinology | ECE2022

Central pontine myelinolysis: Case report

Gonzalez Lazaro Paloma , Contreras Pascual Cristina , Montalban Mendez Cristina , Moreno Tirado Antonio , Zhao Montero Benitez Maria , Jimenez Torrecilla Pedro

Introduction: Central pontine myelinolysis (CPM) is a rare and potentially life-threatening complication of a sudden rise in serum osmolality. Along with extrapontine myelinolysis, it is part of the osmotic demyelination syndrome (ODS). Known risk factors include severe hyponatremia, alcoholism, thiazide use, hypokalemia, and malnourishment.Case report: We report the case of a 31-year-old-male with history of alcohol and cannabis dependence, who had atte...

ea0090p617 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Case Report: Atypical presentation of central pontine myelinolysis in hyperglycemia

Gonzalez Lazaro Paloma , Contreras Pascual Cristina , Moreno Tirado Antonio , Zhao Montero Benitez Maria , Jimenez Torrecilla Pedro , Gomez Garcia Ines

Central pontine myelinolysis (CPM) is a neurological disorder typically caused by rapid correction of severe chronic hyponatremia. Conditions causing a hyperosmolar state can also cause CPM, but it is rarely seen in diabetes. We report the case of a 33-year-old woman with personal history of Type 1 Diabetes since she was 9 years old with very poor metabolic control (A1hbC 15%) and microvascular complications, who attended the emergency department due to left hemicranial headac...

ea0090p258 | Thyroid | ECE2023

Widely invasive follicular thyroid carcinoma. A case report

Contreras Pascual Cristina , Gonzalez Lazaro Paloma , Zhao Montero Benitez Maria , Jimenez Torrecilla Pedro , Almendra Alvarado Rosas Karol

Follicular thyroid carcinoma (FTC) is the second most common type of thyroid cancer, making up about 10 to up to 15% of all thyroid cancers. It is called a ‘well differentiated’ thyroid carcinoma, like papillary thyroid cancer, but it is typically more aggressive than this. We report the case of a 75-year-old man with personal history of Type 1 Diabetes since he was 25 years old, with severe nonproliferative diabetic retinopathy (blindness) and multinodular goiter. I...

ea0090ep694 | Pituitary and Neuroendocrinology | ECE2023

Thyrotropin-secreting pituitary tumor: a rare entity

Torrecilla Pedro Jimenez , Gonzalez Lazaro Paloma , Moreno Tirado Antonio , Montero Benitez Maria Zhao , Lomas Meneses Amparo , Del Val Zaballos Florentino , Contreras Pascual Cristina

TSH-secreting pituitary adenomas are a rare cause of hyperthyroidism. The diagnosis should be considered in all hyperthyroid patients, especially those with a diffuse goiter and no extrathyroidal manifestations of Graves’ disease. Most TSH-secreting adenomas secrete only TSH. Most patients have the typical symptoms and signs ofhyperthyroidism (eg, palpitations, tremor, heat intolerance), but a few patients have mild or even no hyperthyroid symptoms. Other clinical feature...

ea0090ep842 | Pituitary and Neuroendocrinology | ECE2023

Spontaneous involution of a cystic pituitary adenoma

Zhao Montero Benitez Maria , Gonzalez Lazaro Paloma , Moreno Tirado Antonio , Jimenez Torrecilla Pedro , Contreras Pascual Cristina , Del Val Zaballos Florentino , Lomas Meneses Amparo , Gomez Garcia Ines

Pituitary adenomas (PAs) account for 15-20% of intracranial tumors. PA with a cystic component are characterized in the MRI by a sellar, symmetrical, round or ovoid mass that enhances on T1- or T2-weighted images but does not concentrate gadolinium. We present the case of a 48-year-old man who in a headache study by Neurology requested a CT scan showing a cystic pituitary macroadenoma of 1.25cm confirmed by pituitary MRI. In the initial analysis, the pituitary function was pre...

ea0063ep88 | Pituitary and Neuroendocrinology | ECE2019

Secondary amenorrhea as unique manifestation of acromegaly due to giant pituitary adenoma

Contreras Pascual Cristina , Gonzalez Lazaro Paloma , Silva Fernandez Julia , del Val Zaballos Florentino , Garcia-Manzanares Vaquez-de Agredos Alvaro , Javier Gomez Alfonso Francisco , Rosa Gomez Garcia Ines

Introduction: Pituitary adenomas are considered to be benign tumors that are diagnosed by its sympthoms (secondary to compression or hormonal secretion) or incidentally in an imaging technique performed because of another reason. ‘Silent’ somatotrophinomas are very rare. This type of adenoma is typically large and despite it presents with mild or no acromegalic features it usually develops hormone secretion.A case report: A 29-year-old spanish ...

ea0056p761 | Neuroendocrinology | ECE2018

Recurrence of hyperprolactinemia after dopamine agonists withdrawal

Contreras Pascual Cristina , Gonzalez Lazaro Paloma , Silva Fernandez Julia , Gomez Garcia Ines , Maria Torres Arroyo Belvis , del Val Zaballos Florentino , Javier Gomez Alfonso Francisco , Garcia Manzanares Vazquez Alvaro

Introduction: Prolactinomas are the most common tumors among functional pituitary adenomas and they constitute 40% of all pituitary tumors. Dopamine agonists (DA) are considered the primary treatment of prolactinoma. DA can lead to complete remission (including eradicacion of the tumor), allowing discotinuation of treatment. So far, there aren’t clinical criteria with sufficient predictive value for long-term remission.Objective: To assess the effec...

ea0073aep760 | Thyroid | ECE2021

Graves’ Disease after COVID-19

Moreno Tirado Antonio , Paloma González Lázaro , Contreras Pascual Cristina , Montalban Mendez Cristina , Maria Zhao Montero Benítez , Florentino Del Val Zaballos

IntroductionGraves’ Disease is an autoimmune syndrome that include hyperthyroidism, goiter, thyroid eye disease, and occasionally, a dermopathy called pretibial or localized myxedema. As each autoinmune ailment to develop in sufferers with genetic susceptibility after a certain environmental exposure (infection, stress…). COVID-19 can cause both pulmonary and systemic inflammation, potentially determining multi-organ dysfunction. Since the out...

ea0081p379 | Endocrine-Related Cancer | ECE2022

First case report of a natural killer T (NK/T) extranodal nasal lymphoma presenting as a diabetes insipidus

Alvarado Rosas Karol Almendra , Sacoto Valeria Gonzalez , Serrano Urzaiz Leticia , Lacarta Benitez Macarena , Contreras Pascual Cristina , Lopez Alaminos Maria Elena , Trincado Pablo , De Diego Garcia Patricia , Acha Perez Javier

A 52-year-old male patient with no past medical history of interest was admitted to our Endocrinology Unit with a clinical course developed in the last month of sudden polyuria, nocturia and polydipsia (8 liters/day) associated with bilateral low back and leg pain, a right-side nasal congestion with eye swelling and paresthesia. Physical examination revealed a doubtful thickening of the nasal mucosa and several two-cm- scattered erythematous disseminated skin lesions. Blood sa...